TRACON Pharmaceuticals Inc – Analysts at Jefferies Group upped their Q1 2017 earnings estimates for shares of TRACON Pharmaceuticals in a research note issued to investors on Wednesday. Jefferies Group analyst B. Abrahams now forecasts that the brokerage will earn per share for the quarter, up from their prior estimate of .
Category: Investment Banking
Check Cap LTD (Chek) Coverage Initiated by Analysts at Rodman & Renshaw
The brokerage issued a buy rating and a $6.00 price target on the stock. Separately, Maxim Group set a $6.00 target price on shares of CHECK CAP LTD and gave the company a buy rating in a report on Monday, October 24th.